Frazier Life Sciences Acquisition Corp. II

S-1 filed

Price $10.00 · 7,500,000 shares · Gross proceeds $70,500,000

Frazier Life Sciences Acquisition Corp. II is conducting an initial public offering (IPO) with underwriters, including Jefferies, who will purchase shares under an underwriting agreement subject to conditions. The offering includes a $0.60 per share underwriting discount, with $0.20 payable at closing and $0.40 deferred to a trust account, released only upon completing an initial business combination. Lock-up periods restrict founders, officers, and directors from transferring shares for 180 days, with exceptions for certain transfers. The underwriters may engage in market-making activities, but this is not guaranteed. The company intends to list on Nasdaq under the symbol "FLSC," and there are risks related to liquidity, market volatility, and the success of the business combination.

DRS filed

Frazier Life Sciences Acquisition Corp. II has filed a preliminary prospectus (DRS) for its initial public offering (IPO), aiming to raise capital through a special purpose acquisition company (SPAC) structure. The offering includes underwriting discounts and commissions of $4.5 million, with $1.5 million payable upon closing and $3 million in deferred fees held in a trust account. The company intends to list on Nasdaq under the symbol 'FLSC' and has entered into contractual transfer restrictions for insiders and underwriters, including lock-up periods for founder shares and private placement shares. The underwriter, Jefferies, has agreed to stabilization activities and has a right of first refusal for future financings related to the company's initial business combination.